Observational analysis examined adherence to follow-up colonoscopy after positive mt-sDNA or FIT/FOBT results, indicating differences across payer types.
Introduction A positive result from a multi-target stool DNA (mt-sDNA) test, fecal immunochemical test (FIT), or fecal occult blood test (FOBT) requires timely follow-up colonoscopy (FU-CY) to minimize colorectal cancer (CRC) incidence and reduce CRC-related mortality. To examine differences in FU-CY adherence between patients who received a positive mt-sDNA test or FIT/FOBT result by payer type.
No takes yet. Share an insight, caveat, or question.
Greene et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: